A list of recently filed public merger agreements as tracked by What's Market. What's Market provides a continuously updated database of public merger agreements that allows you to analyze and compare negotiated terms, including break-up and reverse break-up fees, across multiple deals. What's Market also contains links to the underlying public documents.
One agreement for US public company acquisitions with a deal value of $100 million or more was filed this past week.
On April 27, 2016, Abbott Laboratories agreed to acquire medical device manufacturer St. Jude Medical, Inc. in a cash and stock transaction valued at $25 billion as of the day before the signing date.
For additional public merger agreement summaries, see What's Market.